SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-003338
Filing Date
2024-01-23
Accepted
2024-01-22 19:42:43
Documents
13
Period of Report
2024-01-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40596
2 COMMON STOCK PURCHASE WARRANT ISSUED TO BOUSTEAD SECURITIES ex4-1.htm EX-4.1 99746
  Complete submission text file 0001493152-24-003338.txt   337026

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE mgrx-20240118.xsd EX-101.SCH 3033
4 XBRL LABEL FILE mgrx-20240118_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE mgrx-20240118_pre.xml EX-101.PRE 22371
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3424
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

IRS No.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 24550214
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)